In previous work we reported that a podocyte-specific deletion of Myh9 in mice (PodΔMyh9) on the C57BL/6 strain background had no overt phenotype but instead resulted in a predisposition to glomerulosclerosis in response to a second injury from Adriamycin [3]. This evidence concerns the gene MYH9 and glomerulosclerosis.